Biomarker analysis from a phase I/I1b study of regorafenib and nivolumab (rego/nivo) in microsatellite stable (MSS) colorectal cancer (CRC).-MedSci.cn

Biomarker analysis from a phase I/I1b study of regorafenib and nivolumab (rego/nivo) in microsatellite stable (MSS) colorectal cancer (CRC).

Yu, J; Kim, Y; Mehta, R; Miao, RY; Strosberg, JR; Imanirad, I; Kim, DW; Kim, RD

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (): 188

科室
- - 订阅+
  - 更多科室
工具
服务